By combining anatomical fidelity with reproducibility, NRSS offers a novel way to train surgeons, validate clinical trials, and expand access to advanced techniques worldwide.
David Almeida, MD, MBA, PhD
Advertisement
Articles by David Almeida, MD, MBA, PhD
At ARVO 2025, in Salt Lake City, Utah, David Almeida, MD, MBA, PhD, talked about 12-month results from the PAVIA phase 2 trial of EYP-1901 in nonproliferative diabetic retinopathy.
Advertisement
Latest Updated Articles
David Almeida, MD, MBA, PhD, advances ophthalmic training with near real surgical specimensPublished: September 17th 2025 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Evolving glaucoma therapy: A new era of interventional strategies
2
Precision strategy: Optimizing visual outcomes with advanced small-aperture lenses
3
Throwback Series: Managing bilateral diabetic macular edema early in practice
4
ICYMI: AAO 2025 showcases new technologies and continued research
5
.png "Optometry Times"){kind=logo}
